- Home
- AKRO vs NMRK Comparison
AKRO vs NMRK Comparison
Compare AKRO & NMRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- NMRK
- Stock Information
- Founded
- AKRO 2017
- NMRK 1929
- Country
- AKRO United States
- NMRK United States
- Employees
- AKRO N/A
- NMRK N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- NMRK Real Estate
- Sector
- AKRO Health Care
- NMRK Finance
- Exchange
- AKRO Nasdaq
- NMRK Nasdaq
- Market Cap
- AKRO 3.6B
- NMRK 3.4B
- IPO Year
- AKRO 2019
- NMRK 2017
- Fundamental
- Price
- AKRO $46.27
- NMRK $19.69
- Analyst Decision
- AKRO Strong Buy
- NMRK Strong Buy
- Analyst Count
- AKRO 8
- NMRK 5
- Target Price
- AKRO $80.38
- NMRK $17.50
- AVG Volume (30 Days)
- AKRO 915.6K
- NMRK 1.3M
- Earning Date
- AKRO 11-07-2025
- NMRK 11-04-2025
- Dividend Yield
- AKRO N/A
- NMRK 0.64%
- EPS Growth
- AKRO N/A
- NMRK 44.43
- EPS
- AKRO N/A
- NMRK 0.36
- Revenue
- AKRO N/A
- NMRK $2,983,234,000.00
- Revenue This Year
- AKRO N/A
- NMRK $17.66
- Revenue Next Year
- AKRO N/A
- NMRK $9.19
- P/E Ratio
- AKRO N/A
- NMRK $52.44
- Revenue Growth
- AKRO N/A
- NMRK 17.28
- 52 Week Low
- AKRO $21.34
- NMRK $9.65
- 52 Week High
- AKRO $58.40
- NMRK $19.70
- Technical
- Relative Strength Index (RSI)
- AKRO 51.29
- NMRK 73.68
- Support Level
- AKRO $41.80
- NMRK $18.76
- Resistance Level
- AKRO $45.44
- NMRK $19.70
- Average True Range (ATR)
- AKRO 1.97
- NMRK 0.52
- MACD
- AKRO 0.06
- NMRK -0.04
- Stochastic Oscillator
- AKRO 75.76
- NMRK 98.77
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About NMRK Newmark Group Inc.
Newmark Group Inc is a commercial real estate advisory firm. It offers services, including leasing and corporate advisory services, investment sales, commercial mortgage brokerage, appraisal and valuation, project management, and property, among others. Newmark offers a diverse array of integrated services and products designed to meet the full needs of both real estate investors/owners and occupiers. The company provides real estate strategic consulting and systems integration services to CFI's clients including many Fortune and Forbes companies, owner-occupiers, government agencies, healthcare, and higher education clients.